Systemic immune mediators reflect tumour‐infiltrating lymphocyte intensity and predict therapeutic response in triple‐negative breast cancer
Lopes, Ananda D., Galdino, Nayane A. L., Figueiredo, Amanda B., Brianese, Rafael C., Morais, Katia L. P., De Brot, Marina, Osório, Cynthia A. B. T., Teixeira‐Carvalho, Andrea, Calsavara, Vinicius F., Evangelista, Guilherme F. B., Alves, Natalia S., Makdissi, Fabiana B., Sanches, Solange M., Cordeiro de Lima, Vladmir C., Carraro, Dirce M., Gollob, Kenneth J.
Published in Immunology (01.06.2023)
Published in Immunology (01.06.2023)
Get full text
Journal Article
Abstract P2-09-04: Reclassification of variant of unknown significance in BRCA1 and BRCA2 genes based on loss of heterozigosity assay
Carraro, Dirce M, Palmero, Edenir I, Berra, Carolina M, Torrezan, Giovana T, Brianese, Rafael C, Fernandes, Gabriela C, Barrera, Angelica M Gutierrez, Galvo, Henrique C, Formiga, Maria NC, Arun, Banu K
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract P5-01-19: Circulating tumor DNA (ctDNA) analysis for investigating resistance to chemotherapy with DNA-damage agents in patients with hereditary or sporadic triple-negative breast cancer
Carraro, Dirce M, Brianese, Rafael C, Torrezan, Giovana T, de Brot, Marina, de Paula, Claudia AA, Formiga, Maria NC, Sanches, Solange M, de Lima, Vladmir CC, Makdissi, Fabiana BA
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article